Daekyo Investment
VC Fund
Seoul, South Korea
Daekyo Investment is a venture capital firm specialized in development of venture industry.
- Total investments:
- 61
- Last investment:
- Lead investor:
- 16%
Last updated:
For AI agents: llms.txt
Industries Daekyo Investment invests in
Stages Daekyo Investment invests in
Countries Daekyo Investment invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $1.1M–$13M
- Series A
- $1.5M–$8.7M
- Series B
- $497k–$17M
Investment Focus
Industry
- Software 9 (15%)
- Education 6 (10%)
- Mobile Apps 6 (10%)
- Biotechnology 6 (10%)
- Manufacturing 6 (10%)
Stage
- Series A 25 (41%)
- Seed 15 (25%)
- Series B 14 (23%)
- Funding Round 1 (2%)
- Private Equity 1 (2%)
Country
- South Korea 45 (74%)
- Hong Kong 1 (2%)
- United States 1 (2%)
- United Kingdom 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jin Seong-tae
CEO
|
CEO | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
MOAIS
|
MOAIS develops a smartphone AI solution that analyzes golf swing problem and offers a lesson solution. It is an on-device AI optimized for smart phones, has a video pose estimation, video segmentation, video classification, video object detection, and image processing of golf swing video. | $3.7M / Series B / Apr 30, 2026 | |
Redrob
|
McKinley & Rice is a software development and outsourcing company. | $8.5M / Series A / Nov 20, 2025 | |
AD System
|
AD System focuses on the development, manufacturing, sales and repairing of drones and other unmanned aerial vehicles. | $2.2M / Seed / Jun 19, 2025 | |
Canteen9
|
Canteen9 is the producer of supplement products intended to provide a well-balanced diet of essential nutrients for children without excessive intake. The company's product offering includes supplements for eyes, bones, skin, and overall immunity, enabling parents to take care of their children by enhancing their well-being. | $2.2M / Series A / Apr 29, 2025 | |
Elpis Cell Therapeutics
|
Elpis Cell Therapeutics develops individualized cell therapy to cure incurable diseases. | $3.5M / Series A / Feb 21, 2025 | |
Cureverse
|
Cureverse operates a pharmaceutical research and development company for the treatment of encephalopathy and oncology diseases. The company focuses on creating remedies for challenging brain conditions like dementia, thereby assisting healthcare professionals in enhancing human well-being and overall quality of life. | $17.1M / Series B / Jan 17, 2025 | |
TeraView
|
TeraView is the world’s first company devoted to the application of Terahertz light for imaging and spectroscopy. TeraView’s proprietary platform uses the Terahertz spectrum between light and radio waves and offers the advantage of being non-invasive and non-destructive. A key application of the technology is the detection of faults and qualityvariations in semiconductor integrated circuits. In addition, studies have demonstrated how Terahertz uniquely and non invasively provides 3 dimensional structural and chemical information in a diverse range of applications, including weapons/explosives hidden below clothing, the contents of tablets and capsules in the pharmaceutical industry, and other objects normally invisible to conventional detection techniques. Other markets for the technology exist in medical imaging of cancer and industrial inspection which are explored via commercial partners. Headquartered in Cambridge, UK, TeraView was spun-out of the Toshiba Cambridge Research Laboratory in April 2001. Sales and support are available throughout Europe, North America and the Far East either directly or through a network of distributors. | $7.2M / Private Equity / Nov 29, 2024 | |
33M2
|
33M2 is a housing rental platform. The company's platform connects tenants looking for a place to stay in Korea for a short period, such as for business trips, studies, and travel, enabling tourists and students with a network of numerous lessees to find rental homes. | $1.8M / Series A / Oct 21, 2024 | |
Inserasolution
|
Inserasolution produces high-performance Fast & Fine Steering Mirrors for laser-based space optical communications and sophisticated defense systems. | $2.4M / Seed / Oct 15, 2024 | |
Unastella
|
Unastella is an aerospace company developing human spaceflight technologies, including launch vehicles and suborbital tourism systems. The company focuses on advancing reusable rocket technology and future space travel infrastructure for civilian space exploration missions. Unastella aims to support the growth of private human spaceflight andnext-generation aerospace innovation. | $14.6M / Series A / Sep 25, 2024 | |
| See all 61 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Daekyo Investment invest in?
Daekyo Investment invests primarily in Software, Education and Mobile Apps startups, most often at Series A and Seed stage. Most of the 61 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Daekyo Investment's check size?
Daekyo Investment typically joins rounds of $1.1M–$13M at Seed, $1.5M–$8.7M at Series A and $497k–$17M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Daekyo Investment participates in.
How do I contact Daekyo Investment?
Public channels for Daekyo Investment include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Daekyo Investment?
The team at Daekyo Investment includes Jin Seong-tae (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
